Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342.
Herbst
Roy S
RS
Department of Thoracic/Head and Neck Medical Oncology, Section of Thoracic Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. rherbst@mdanderson.org
Kelly
Karen
K
Chansky
Kari
K
Mack
Philip C
PC
Franklin
Wilbur A
WA
Hirsch
Fred R
FR
Atkins
James N
JN
Dakhil
Shaker R
SR
Albain
Kathy S
KS
Kim
Edward S
ES
Redman
Mary
M
Crowley
John J
JJ
Gandara
David R
DR